Clinical trials
Phase 3 Carcinoma, Hepatocellular trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 1 |
| 2015 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 2 |
| Eli Lilly and Company | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Bristol-Myers Squibb | 1 |
| Can-Fite BioPharma | 1 |
| Eisai Limited | 1 |
| Exelixis | 1 |
| Novartis Pharmaceuticals | 1 |
| SillaJen, Inc. | 1 |
| University of Birmingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 13 |
| Neoplasms | 4 |
| Liver Neoplasms | 3 |
| Carcinoma | 2 |
| Fibrosis | 1 |
| Hepatoblastoma | 1 |
| Vaccinia | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.